Drug points: Weight loss associated with levetiracetam

BMJ

Volumn 327, Issue 7420, 2003, Pages 905-

  Hadjikoutis, s ^a   Pickersgill, T P ^a   Smith, P E M ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM;

ANOREXIA; ARTICLE; DIARRHEA; EPILEPSY; HUMAN; PICA; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; ANTICONVULSANTS; BODY WEIGHT; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; WEIGHT LOSS;

EID: 0142010595     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.327.7420.905     Document Type: Article

References (4)

1. Shorvon S. Handbook of epilepsy treatment. Oxford: Blackwell Science, 2000.
2. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA, RPS, 2003: 231–2. (No 45.)
3. Glanser TA. Topiramate. Epilepsia 1999; 40(suppl 5):S71–S80.
4. Faught, Ayala R, Montowris GG, Leppik IE. Randomised controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2000; 57: 1774–9.